Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 10/20 | 0.47 |
| ▸ | CNR2 | P34972 | 6/20 | 0.47 |
| ▸ | FBP1 | P09467 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | P4HB | P07237 | 5/20 | 0.41 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.39 |
| ▸ | MEF2D | Q14814 | 1/20 | 0.39 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.39 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9369237 | 1.00 | CNR1 (0.47) | CNR1CNR2FBP1GLAP4HB | |
| SCHEMBL9186668 | 0.82 | FBP1 (0.61) | FBP1P4HB | |
| SCHEMBL21574844 | 0.82 | FBP1 (0.61) | FBP1P4HB | |
| SCHEMBL9186663 | 0.82 | FBP1 (0.61) | FBP1P4HB | |
| SCHEMBL1687873 | 0.79 | FBP1 (0.57) | FBP1P4HB | |
| SCHEMBL21574806 | 0.79 | FBP1 (0.57) | FBP1P4HB | |
| SCHEMBL9190221 | 0.79 | FBP1 (0.57) | FBP1P4HB | |
| SCHEMBL1687907 | 0.79 | FBP1 (0.57) | FBP1P4HB | |
| SCHEMBL5199115 | 0.79 | FBP1 (0.40) | CNR1CNR2FBP1GLAP4HB | |
| SCHEMBL1687910 | 0.79 | FBP1 (0.65) | FBP1P4HB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0600084-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-08 | — | — | EP | disclosed |
| WO-1993003012-A1 | INDOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1993-02-18 | — | — | WO | disclosed |